Tumor-specific adaptive immune responses, including the activation of cytotoxic T cells (CD8+ T cells), rely on type I interferon signaling from antigen-presenting cells, with the cGAS-STING pathway being a critical mediator of type I interferon activation (106). This evidence concerns the gene CD8A and neoplasm.